Replimune Group Inc. (REPL)
NASDAQ · Healthcare
Replimune Group Inc. EBITDA 2020–2025
Replimune Group Inc. annual/quarterly ebitda history and growth rate from 2020 to 2025. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Replimune Group Inc. ebitda for the quarter ending December 31, 2025 was -71.3 M, a 4.90% increase year-over-year.
- Replimune Group Inc. ebitda for the twelve months ending December 31, 2025 was -321.0 M.
- Replimune Group Inc. annual ebitda for 2025 was -256.6 M, a 11.82% increase from 2024.
- Replimune Group Inc. annual ebitda for 2024 was -229.4 M, a 29.33% increase from 2023.
- Replimune Group Inc. annual ebitda for 2023 was -177.4 M, a 55.53% increase from 2022.
- Replimune Group Inc. annual ebitda for 2022 was -114.1 M.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Replimune Group Inc. EBITDA — FAQ
Replimune Group Inc. (REPL) ebitda over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see REPL's ebitda history?
The chart and table above show Replimune Group Inc.'s ebitda by year and by quarter, including the growth rate.